Table 1.
Original country of patient | Total | Percentage % | No of total with site for | Genotype | ||||
---|---|---|---|---|---|---|---|---|
PstI | BglI | A PstI+/BglI− |
B PstI+/BglI+ |
C PstI−/BglI+ |
D PstI−/BglI− |
|||
Kuwait | 4 | 6.7% | 4 | 3 | 1 (25%) | 3 (75%) | 0 | 0 |
Saudi | 1 | 1.7% | 1 | 1 | 0 | 1 (100%) | 0 | 0 |
India | 31 | 51.7.% | 31 | 27 | 4 (13%) | 27 (87%) | 0 | 0 |
Sri Lanka | 11 | 18.3% | 11 | 9 | 2 (18%) | 9 (82%) | 0 | 0 |
Bangladesh | 5 | 8.3% | 5 | 5 | 0 | 5 (100%) | 0 | 0 |
Philippine | 7 | 11.7% | 6 | 7 | 0 | 6 (86%) | 1 (14%) | 0 |
Ethiopia | 1 | 1.7% | 1 | 1 | 0 | 1 (100%) | 0 | 0 |
Total | 60 | 7 (11.66%) | 52(86.6%) | 1(1.66%) | 0 |